Sun Pharma revises upwards price to fully acquire Taro to $43 per share
Sun Pharmaceutical Industries on Tuesday said it has revised upwards the price at which it proposed to fully acquire
Continue readingThe Number One Finance & Business Blog!
Sun Pharmaceutical Industries on Tuesday said it has revised upwards the price at which it proposed to fully acquire
Continue readingSun Pharmaceuticals said Saturday that it has proposed the full acquisition of Israel-based Taro Pharmaceuticals through a reverse triangle merger.
Continue reading